Blueprint Medicines Corporation Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 7.12 M | $658.51 M | 100.00% | 11.23% |
| VANGUARD GROUP INC | 11/13/2024 | 6.68 M | $618.22 M | 2.22% | 10.54% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 5.39 M | $498.32 M | -8.28% | 8.50% |
| FMR LLC | 11/13/2024 | 4.52 M | $417.80 M | -6.56% | 7.13% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 3.96 M | $366.73 M | 22.53% | 6.26% |
| STATE STREET CORP | 11/14/2024 | 2.77 M | $255.83 M | 16.21% | 4.36% |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 11/08/2024 | 1.67 M | $154.92 M | 5.07% | 2.64% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.48 M | $136.94 M | 1.42% | 2.34% |
| JANE STREET GROUP, LLC | 11/15/2024 | 1.38 M | $127.79 M | 100.00% | 2.18% |
| MACQUARIE GROUP LTD | 11/14/2024 | 1.26 M | $116.89 M | -3.69% | 1.99% |
| JPMORGAN CHASE & CO | 12/26/2024 | 1.22 M | $113.04 M | -0.21% | 1.93% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 1.22 M | $112.64 M | 6.91% | 1.92% |
| LORD, ABBETT & CO. LLC | 12/13/2024 | 1.18 M | $108.98 M | -1.00% | 1.86% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 1.17 M | $107.91 M | 3.48% | 1.84% |
| INVESCO LTD. | 11/12/2024 | 900,356 | $83.28 M | -3.44% | 1.42% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 877,005 | $81.12 M | 0.23% | 1.38% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 815,071 | $75.39 M | 1.54% | 1.29% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 768,776 | $71.11 M | -68.75% | 1.21% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 748,692 | $69.26 M | -5.43% | 1.18% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 721,632 | $66.75 M | -2.38% | 1.14% |
| ALKEON CAPITAL MANAGEMENT LLC | 11/14/2024 | 718,928 | $66.50 M | -19.58% | 1.13% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 11/14/2024 | 672,436 | $62.20 M | 33.73% | 1.06% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 618,787 | $57.24 M | -1.41% | 0.98% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 597,232 | $55.24 M | 9.28% | 0.94% |
| BROWN ADVISORY INC | 11/13/2024 | 593,768 | $54.92 M | -3.92% | 0.94% |
| JANE STREET GROUP, LLC | 11/15/2024 | 563,400 | $52.11 M | 100.00% | 0.89% |
| NORTHERN TRUST CORP | 11/13/2024 | 555,818 | $51.41 M | 2.20% | 0.88% |
| MORGAN STANLEY | 11/14/2024 | 536,362 | $49.61 M | 27.32% | 0.85% |
| MAN GROUP PLC | 11/14/2024 | 518,616 | $47.97 M | 32.00% | 0.82% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 496,087 | $45.89 M | 161.09% | 0.78% |
| CLEARBRIDGE INVESTMENTS, LLC | 11/12/2024 | 481,885 | $44.57 M | 118.07% | 0.76% |
| WOODLINE PARTNERS LP | 11/14/2024 | 453,578 | $41.96 M | -48.47% | 0.72% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 411,455 | $38.06 M | 1.92% | 0.65% |
| EMERALD ADVISERS, LLC | 10/29/2024 | 375,866 | $34.77 M | 10.16% | 0.59% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 360,700 | $33.36 M | 1.78% | 0.57% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 348,704 | $32.26 M | 50.51% | 0.55% |
| TWIN TREE MANAGEMENT, LP | 11/13/2024 | 336,400 | $31.12 M | 98.35% | 0.53% |
| FISHER ASSET MANAGEMENT, LLC | 11/12/2024 | 335,350 | $31.02 M | -0.24% | 0.53% |
| MARSHALL WACE, LLP | 11/14/2024 | 333,767 | $30.87 M | -5.11% | 0.53% |
| CASDIN CAPITAL, LLC | 11/14/2024 | 326,378 | $30.19 M | 0.00% | 0.51% |
| ENSIGN PEAK ADVISORS, INC | 11/14/2024 | 326,146 | $30.17 M | 6.47% | 0.51% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 324,614 | $30.03 M | 103.12% | 0.51% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2024 | 315,000 | $29.14 M | -17.75% | 0.50% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 296,331 | $27.41 M | 8.18% | 0.47% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2024 | 290,000 | $26.83 M | -14.71% | 0.46% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 10/29/2024 | 288,540 | $26.69 M | 3.67% | 0.46% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 287,560 | $26.60 M | 26.91% | 0.45% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 281,014 | $25.99 M | -17.23% | 0.44% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 276,344 | $25.56 M | 109.28% | 0.44% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 266,500 | $24.66 M | -17.62% | 0.42% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Blueprint Medicines Corporation institutional Ownership - FAQ's
During the previous two years, 405 institutional investors and hedge funds held shares of Blueprint Medicines Corporation. The most heavily invested institutionals were:
JENNISON ASSOCIATES LLC: 360,208
Empirical Asset Management, LLC: 26,921
OAK RIDGE INVESTMENTS LLC: 14,197
Diversified Trust Co: 7,418
STEPHENS INC /AR/: 3,684
KBC Group NV: 2,625
101.99% of Blueprint Medicines Corporation stock is owned by institutional investors.
Institutional investors have bought a total of 85.81 M shares in the last 24 months. This purchase volume represents approximately $9.81 B in transactions.